Artwork
iconShare
 
Manage episode 504134061 series 3449935
Content provided by Jonathan Kaskey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jonathan Kaskey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health.

They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks.

  • Introduction and startling data on prescription abuse
  • Welcome and guest introduction
  • Paul Howe's breakfast routine
  • Career background and current role
  • Challenges with opioid prescriptions
  • Risk stratification and mitigation for patients
  • Pharmaceutical manufacturing quotas and regulation
  • Future outlook for pain management and public health

Pharma Sessions is hosted by Jonathan Kaskey
Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/
Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

  continue reading

37 episodes